This content is for members only
On October 17, 2018, Form 4 insider transactions by the CEO of Ever-Glory International Group, (NASDAQ:EVK), where he made a direct purchase of 174,800 shares, prompted us to add the stock to our model swing trade portfolio at $3.25. While […]
This content is for members only
Reading in between the lines of press releases is a necessary part of the investment research process to avoid getting tricked by management into buying their stocks. One of the worst feelings as an investor is losing money on an […]
This content is for members only
This content is for members only
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) reported impressive results on December 1, 2018 for its lymphoma drug candidate Selinexor, noting patients who experienced a complete or partial response in a 125-patient trial had a median overall survival rate of 29.7 months. Previously published […]
Over the last couple of years, I have been making an effort to watch video presentations by educators and investors I respect. Most recently I have been focusing on investing emotion. I then like to transcribe them, so I can […]